A clinical trial is a study that tests how well new medical techniques work. An important characteristic to any good clinical trial is appropriate screening and randomization practices. Planning is the foundation of a good clinical trial. The steps you take before distributing the first treatment or medication can lay the foundation for positive patient experiences and simple data collection.
In a trial, the development stage can ensure the data is defendable, accurate, and usable. Thus, you’ll be able to confidently present your information and bring a drug to market at the right time. However, only the right tools can help you preplan successfully.
Read as we discuss how EDC clinical trial systems can streamline this process and help you move forward with your clinical trials:
Using pre-screening to identify the right participants
Recruitment should be done effectively because it’s a huge part of clinical trial development. Although an organization may have a number of interested participants, its recruitment efforts will go down the drain if none of them are qualified to receive the medication or treatment. Ineffective recruitment can stagnate the trial process as researchers invest more time in finding the right patients.
To identify whether or not a patient is qualified for a clinical trial, adopting an effective pre-screen process can help.
When a patient is identified, the organization conducting the research should have an effective screening process that requires little to no travel and is minimally invasive. Such processes have become possible with technologies like remote sampling.
Plus, identified candidates may submit samples at any time from wherever they are without visiting the research facility. Sample collection doesn’t require extensive training.
Simplifying the randomization process
When the researchers have the right patients ready to begin a clinical trial, they can move forward with different treatment groups. Safeguarding the trial data’s integrity and removing bias is possible through randomization.
Although randomization may be different for different trials, the aim is to ensure demographic factors don’t produce biased results.
Randomization doesn’t really have any cons. By doing it, research teams gain a lot of benefits without losing anything. Numerous studies also compensate for needing participants to be on a placebo by making sure that once the study’s primary portion is done and dusted, they can access the investigational medicine.
Some EDC clinical trial systems have a randomization simulator that allows you to assess a number of potential participants. To minimize any bias in your trial design, set various goals and parameters.
ClinicalPURSUIT offers top-of-the-line clinical trial data management solutions
Whether you’re in search of randomization and drug supply management solutions or electronic patient-reported outcome software, ClinicalPURSUIT can help.
Get in touch with us now for more information!
